ENTRY       D11857            Mixture   Drug
NAME        Aclidinium bromide and formoterol fumarate;
            Duaklir pressair (TN)
PRODUCT     DUAKLIR PRESSAIR (AstraZeneca Pharmaceuticals LP)
COMPONENT   Aclidinium bromide [DR:D08837], Formoterol fumarate [DR:D01373]
CLASS       Metabolizing enzyme substrate
             DG02924  UGT substrate
REMARK      ATC code: R03AL05
            Product: D11857<US>
EFFICACY    Bronchodilator
  DISEASE   Chronic obstructive pulmonary disease [DS:H01714]
COMMENT     Formoterol is primarily metabolized by UDP-glucuronosyltransferase (UGT).
METABOLISM  Enzyme: UGT [KO:K00699]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
               R03A ADRENERGICS, INHALANTS
                R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
                 R03AL05 Formoterol and aclidinium bromide
                  D11857  Aclidinium bromide and formoterol fumarate &lt;US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Bronchodilator Combinations
               Aclidinium Bromide/ Formoterol Fumarate
                D11857  Aclidinium bromide and formoterol fumarate
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG02924  UGT substrate
               D11857  Aclidinium bromide and formoterol fumarate
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11857
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11857
///
